-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse London Stock ExchangeISIN GB0009252882-
GlaxosmithklineBörse London Stock ExchangeISIN GB0009252882Symbol GSK
-
GlaxosmithklineBörse Börse FrankfurtISIN GB0009252882 WKN: 940561EURSymbol GS7
-
GlaxosmithklineBörse Börse BerlinEURSymbol GS7A
-
GLAXOSMITHKLINE PLC-SPON ADRBörse Börse FrankfurtEURSymbol GS7A
-
GlaxosmithklineBörse Börse StuttgartEURSymbol GS7A
-
GlaxosmithklineBörse Börse MünchenEURSymbol GS7A
-
GlaxosmithklineBörse Gettex System der Börse MünchenEURSymbol GS7A
-
GLAXOSMITHKLINE PLCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse BerlinEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Quotrix System der Börse DüsseldorfEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse HamburgEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse DüsseldorfEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse MünchenEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse StuttgartEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Gettex System der Börse MünchenEURSymbol GS7
-
GlaxosmithklineBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol GS7A
-
GlaxosmithklineBörse Börse HamburgEURSymbol GS7A
-
GlaxosmithklineBörse Quotrix System der Börse DüsseldorfEURSymbol GS7A
-
GlaxosmithklineBörse Börse DüsseldorfEURSymbol GS7A
-
GlaxosmithklineBörse NYSE New York Stock ExchangeISIN GB0009252882 WKN: 940561Symbol GSK
-
GlaxosmithklineBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"USDSymbol GSK.LN
-
GlaxoSmithKline PLC ADRBörse NYSE New York Stock ExchangeISIN US37733W1053 WKN: 940610Symbol GSK
-
INRGLAXOSMITHKLINE PHARMACEUTICALBörse BSE
-
USDGlaxosmithklineBörse Freiverkehr OTC
-
Symbol GS7
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
93.879.525.376 oder 82.199.000.000 oder 81.582.338.640
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
94.066 oder 90.096 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
13.04 oder 18.9
Zahlte zuletzt am 20.05.2021 eine Dividende von 19 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Glaxosmithkline läuft ähnlich wie der DAX (1.29 %) vom 05.07.2021 bis 10.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 1478,4 GBp +0,73%
Aktionärsstruktur der GlaxoSmithKline plc
Portrait der Glaxosmithkline Aktie
Das Unternehmen GlaxoSmithKline plc aus Großbritannien beschäftigt 92.081 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Pharma tätig.
Die Glaxosmithkline Aktie hat inklusive der Dividendenausschüttungen seit dem 05.07.2021 eine Gesamtrendite von 0% erwirtschaftet
Das Unternehmen GlaxoSmithKline plc ist in mehr als 78 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe Select Dividend 30 UCITS ETF (DE) gewichtet Glaxosmithkline mit 6,17% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Glaxosmithkline Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen GlaxoSmithKline plc am höchsten gewichtet ist Insgesamt in 78 ETFs enthalten
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
238 News & Informationen zur Glaxosmithkline Aktie
Dual-antibody drugs effective against COVID-19 variants in animal study By Reuters
Dual-antibody drugs effective against COVID-19 variants in animal study
VG ACQU : 23ANDME HOLDING CO. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS (Form 8-K)
23ANDME HOLDING CO.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
… | June 21, 2021
GSK to boost spending power of pharma business post break-up By Reuters
GSK to boost spending power of pharma business post break-up
GSK to boost spending power of pharma business post break-up
GlaxoSmithKline (GSK.L) will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day on Wednesday, as analysts call on the British drugmaker to boost drug development prospects with takeovers or alliances.
GSK And Vir Biotechnology Announce Continuing Progress Of The COMET Clinical Development Program For Sotrovimab
– Analysis of final Day 29 data from COMET-ICE confirms sotrovimab significantly reduces hospitalization and risk of death in adults with mild-to-moderate
GSK and Vir Biotechnology Announce Continuing Progress of the COMET Clinical Development Program for Sotrovimab
– Analysis of final Day 29 data from COMET-ICE confirms sotrovimab significantly reduces hospitalization and risk of death in adults with mild-to-moderate…
Why I’d buy GSK shares despite the coming dividend cut
GlaxoSmithKline intends to split itself up and reduce its dividends. G A Chester explains why he thinks now is a good time for him to buy GSK shares.
Why I’m buying these 2 FTSE 100 shares for retirement
These two FTSE 100 stocks are at the top of my list when considering the financial options that will provide me with stability in retirement.
Moderna's Post-Covid Vaccines Show Promise in Clinical Trials
Moderna's Post-Covid Vaccines Show Promise in Clinical Trials, Stocks: MRNA,PFE,BNTX,JNJ,GSK, release date:Apr 15, 2021
Why GlaxoSmithKline Stock Jumped Today
An activist investor is reportedly building a significant position in the drugmaker.
Elliott Management has built a large stake in GlaxoSmithKline
I have been buying GlaxoSmithKline stock ahead of the proposed split. An activist hedge fund taking a large stake in the company suggests they want something different. Here is what I am doing now.
Wall Street Opens at Record Highs After Twin Boost From Economy; Dow up 220 Pts By Investing.com
Wall Street Opens at Record Highs After Twin Boost From Economy; Dow up 220 Pts
Upbeat Earnings, Economic Data May Lead To Initial Strength On Wall Street
The major U.S. index futures are pointing to a higher open on Thursday, with stocks likely to move back to the upside following the pullback seen over the course of the previous session.
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020 – read this article along with other careers information, tips and advice on BioSpace
Martin Capital Partners, LLC Buys General Dynamics Corp, Coca-Cola Femsa SAB de CV, Merck Inc, Sells GlaxoSmithKline PLC, Emerson Electric Co, S&P 500 ETF TRUST ETF
Martin Capital Partners, LLC Buys General Dynamics Corp, Coca-Cola Femsa SAB de CV, Merck Inc, Sells GlaxoSmithKline PLC, Emerson Electric Co, S&P 500 ETF TRUST ETF, Stocks: MRK,D,UL,JKHY,RHI,CLX,GD,KOF,HII,INGR,GOOG,GSK,SPY, release date:Apr 14, 2021
GlaxoSmithKline : GSK provides update on feladilimab, an investigational inducible T cell co-stimulatory (ICOS) agonist
GlaxoSmithKline plc today announced, following a recommendation by the Independent Data Monitoring Committee, that it has taken the decision to stop enrolling patients in the phase II INDUCE-3… | April 14, 2021
Tim Jones Joins Grey As Chief Creative Officer, Pharma
NEW YORK, April 14, 2021 /PRNewswire/ — Justine Armour, Chief Creative Officer of Grey New York, today announced that Tim Jones is joining the agency as Chief
Outlook On The End Stage Renal Disease Global Market To 2025 – Competitive Analysis And Impact Of COVID-19
DUBLIN, April 13, 2021 /PRNewswire/ — The “Global End Stage Renal Disease Market (2020-2025) by Disease Type, Treatment Type, End User, Geography, Competitive
GlaxoSmithKline (GLAXF) – I'm Not Buying It (Yet)
While GSK is fundamentally appealing, given current uncertainties, I am choosing superior and safer investments at this time. GSK might become more interesting to me in the future.
How Important Is Novavax's COVID Vaccine Manufacturing Deal With GlaxoSmithKline?
The small biotech is getting critical help from a big pharma company.
Which Stock Is Likely to Be the Biggest Winner: Lilly, Vir, or GlaxoSmithKline?
One of the three clearly has the most upside potential.
3 Stocks That Could Suffer if Biden Gives In to This Pressure
Leaders from across the globe and at home want the new president to break from his past.
GlaxoSmithKline erwartet Gewinnrückgang und will eine stabile Dividende ausbezahlen
Der britische Pharmakonzern GlaxoSmithKline (ISIN: GB0009252882) wird für das vierte Quartal 2020 eine Dividende in Höhe von 23 Pence (ca. 0,26 Euro) ausbezahlen. Im Vorjahr wurden ebenfalls 23 Pence ausgeschüttet. GlaxoSmithKline zahlt seine Dividenden vierteljährlich aus. Als Termin für die Zahlung der Dividende wurde der 8. April 2021 angekündigt. Ex-Dividenden-Tag ist der 18. Februar 2021. Im letzten Jahr wurde damit
A reinvigorated Alzheimer's treatment and gene-therapy setbacks: 3 winners and 3 losers from the healthcare industry's most important event of the year
Gene therapy biotechs were overshadowed and struggled, while a highly debated theory on treating Alzheimer's disease got a boost.
Global Omega 3 Supplements Market Report 2020-2027: Growing Demand for Eicosapentaenoic Acid (EPA) and DHA-based Supplements
/PRNewswire/ — The “Omega 3 Supplements Market Size, Share & Trends Analysis Report by Source (Fish Oil, Krill Oil), by Form (Soft Gels, Capsules), by…
GlaxoSmithKline plc: A High-Yield Stock You May Not Have Considered
This is a look at GlaxoSmithKline plc (NYSE:GSK), a British health-care company that provides generous dividends to American income investors.
Cancer Vaccines Market to reach US $10,688.8 Million By 2028 – Global Insights on Key Trends, COVID-19 Impact Analysis, Growth Drivers, Expansion Plans and Future Outlook: Adroit Market Research
Dallas, Texas, Jan. 15, 2021 (GLOBE NEWSWIRE) — The “Global Cancer Vaccines Market Size 2020, By Type (Preventive Cancer Vaccines, Therapeutic Cancer …
Pfizer Leads Vaccine Stocks As The Most Trusted Name In Covid-19: IBD/TIPP
A growing number of Americans are willing to get a coronavirus vaccine, according to the latest IBD/TIPP Poll. That could help vaccine stocks.
Fear of Vaccine Threatens to Delay Pandemic’s End
After the first vaccines against Covid-19 demonstrated efficacy, public health officials began to foresee a gradual end to the pandemic. Getting there with a minimum of additional suffering will require widespread administration of vaccines, with the goal of achieving so-called herd immunity. Some health specialists warn that vaccine hesitancy — a reluctance to accept immunization — threatens to undermine that target.
Antibiotics Market to Reach USD 39.06 Billion by 2027 at 2.1% CAGR; Surging Cases of Bacterial Infections to Incite Development, states Fortune Business Insights™
Pune, India, Jan. 14, 2021 (GLOBE NEWSWIRE) — The global antibiotics market size is expected to reach USD 39.06 billion in 2027 at a CAGR of 2.1% during …
Expecting 40% CAGR for Global mHealth Apps Market Size Will Reach USD 105.4 Billion by 2026: Facts & Factors
New York, NY, Jan. 13, 2021 (GLOBE NEWSWIRE) — Facts and Factors have published a new research report titled “mHealth Apps Market By Type (Fitness, …
Best shares to buy now? This is how I’d invest £5k today
Gold, pharmaceuticals, or tech stocks? Roland Head looks at five of the best shares he'd buy now if he was starting a new portfolio with £5,000 today.
Operation Warp Speed chief resigns at Biden team's request, will stay through transition, sources say
The scientific leader of the U.S. vaccine effort will stay in the role for 30 days, but won't be chief adviser as of Jan. 20, sources say.
Why Vir Biotechnology Stock Vaulted Higher Today
The biotech announced updates about collaborations with two big partners.
GlaxoSmithKline testet weiteren Antikrper als COVID-19-Medikament – GSK-Aktie tiefer, Vir-Aktie gewinnt
Der britische Pharmakonzern GlaxoSmithKline und die US-Firma Vir Biotechnology wollen ein zweites Antikrper-Mittel zu Behandlung von COVID-19-Patienten testen. 12.01.2021
Stocks making the biggest moves in the premarket: Albertson's, Zoom Video, Lemonade & more
The stocks making the biggest moves in premarket trading include Albertson's, Zoom Video, Lemonade, and more.
COVID-19 Creating Growth Opportunities for Respiratory Drugs Market; Market to Cross USD 25,500 million by the End of 2027 Due to Soaring Burden of Chronic Respiratory Diseases Worldwide
New York, Jan. 12, 2021 (GLOBE NEWSWIRE) — With availability of limited preventive or therapeutic interventions for respiratory viruses resulting in …
What to watch today: Dow set to bounce after drop from record highs
U.S. stock futures rose Tuesday, a day after market declines from record highs.
GSK, Vir to test antibody for Covid-19 treatment
Trial will begin in the first quarter of 2021
Asia Pacific Typhoid Fever Vaccines Market (2020 to 2027) – COVID-19 Impact and Regional Analysis
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) — The “Asia Pacific Typhoid Fever Vaccines Market Forecast to 2027 – COVID-19 Impact and Regional Analysis by …